Product Code: RP-ID-10265622 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10265622
Market Overview:
Global Pen Needles Market Size study, by Type (Standard Pen Needles, Safety Pen Needles) By Length ( 4mm, 5mm, 6mm, 8mm, 10mm, 12mm) By Therapy (Insulin Therapy, Glucagon-Like Peptide-1 (GLP-1) Therapy, Growth Hormone Therapy, Other Therapies) By Mode of Purchase (Retail, Non-Retail) and Regional Forecasts 2019-2026
Global Pen Needles Market is valued approximately USD 1 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2019-2026. Pen needles are used in combination with infusion pens to provide or deliver injectable drugs into the body. A pen needle comprises of a hollow needle which is embedded in a plastic hub and attaches to injection pens. They are commonly used by people with chronic diseases who often require multiple daily injections for instance, in diabetes. Increase in diabetes have driven more people to take insulin that can be self-administered through insulin needle pen. Thus, growing prevalence of chronic diseases coupled with favorable reimbursement policies are key driving factor of market growth. According to the International Diabetic Federation, the number of diabetic patients are growing at a significant pace. As per the source the number of diabetic patients in 2015 were reported to be approximately 425 million globally whereas these number are estimated to grow about 578 million by 2030 and about 700 million by 2045. Further, growing prevalence for biosimilar drugs is expected to create significant growth opportunity in the market over the forecast period. Insulin pen needles are expected for single use however it is known that a significant proportion of people with diabetes do re-use needle pens this is expected to create significant challenge in the market. However, preference for alternative modes of drug delivery impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Pen Needles market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to the growing geriatric population and growing prevalence of diabetes in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing focus of market players developing novel product and improving healthcare infrastructure would create lucrative growth prospects for the Pen Needles market across Asia-Pacific region.
Major market player included in this report are:
Becton, Dickinson and Company
Novo Nordisk
Ypsomed
Owen Mumford, Ltd.
HTL-Strefa
B. Braun Melsungen AG
Terumo Corporation
Ultimed
Allison Medical, Inc.
Artsana S.P.A.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Standard Pen Needles
Safety Pen Needles
By Length:
4mm
5mm
6mm
8mm
10mm
12mm
By Therapy:
Insulin Therapy
Glucagon-Like Peptide-1 (GLP-1) Therapy
Growth Hormone Therapy
Other Therapies
By Mode of Purchase:
Retail
Non-Retail
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Pen Needles Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Novo Nordisk
Ypsomed
Owen Mumford, Ltd.
HTL-Strefa
B. Braun Melsungen AG
Terumo Corporation
Ultimed
Allison Medical, Inc.
Artsana S.P.A.
Related Reports
Proof of Quality & Reliability
